Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Microbial and metabolic profiles of bronchopulmonary dysplasia and therapeutic effects of potential probiotics Limosilactobacillus reuteri and Bifidobacterium bifidum

30 Apr 2022

Abstract excerpt

AIMS: Bronchopulmonary dysplasia (BPD) is a common respiratory disease in newborns; however, there is no effective treatment. We aimed to investigate the effects of the potential probiotics Limosilactobacillus reuteri and Bifidobacterium bifidum on BPD using 16S rDNA sequencing and metabolomics methods. METHODS AND RESULTS: Faecal samples were collected from 10 BPD patients and 10 healthy subjects. 16S rDNA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gut microbiota and health
Share to Infant Nutrition and Health
Share to Neonatal Respiratory Health Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 35488863
DOI: 10.1111/jam.15602

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Microbial and metabolic profiles of bronchopulmonary dysplasia and therapeutic effects of potential probiotics Limosilactobacillus reuteri and Bifidobacterium bifidumPMID 35488863Read ↗

The emerging roles of microbiome and short-chain fatty acids in the pathogenesis of bronchopulmonary dysplasiaSemantic proximity Read ↗

Change of Intestinal Microbiota in Mice Model of Bronchopulmonary DysplasiaSemantic proximity Read ↗

The lower-airway microbiome and metabolome in preterm infants: Identifying potential predictive biomarkers of bronchopulmonary dysplasiaSemantic proximity Read ↗

Oxidative Stress and Bronchopulmonary Dysplasia: Evidences From Microbiomics, Metabolomics, and ProteomicsSemantic proximity Read ↗

The Airway Microbiome and Metabolome in Preterm Infants: Potential Biomarkers of Bronchopulmonary DysplasiaSemantic proximity Read ↗

Increased <i>S. epidermidis</i> in the airway-gut microbiome of infants with bronchopulmonary dysplasiaSemantic proximity Read ↗

Genomics, microbiomics, proteomics, and metabolomics in bronchopulmonary dysplasiaSemantic proximity Read ↗

Pathogenesis of Bronchopulmonary Dysplasia: Role of Oxidative Stress from ‘Omics’ StudiesSemantic proximity Read ↗

Metabolic dysregulation in bronchopulmonary dysplasia: Implications for identification of biomarkers and therapeutic approachesSemantic proximity Read ↗

Phenotypes of Bronchopulmonary Dysplasia.Semantic proximity Read ↗

Biomarkers in neonatology: the new “omics” of bronchopulmonary dysplasiaSemantic proximity Read ↗

The fungal intestinal microbiota predict the development of bronchopulmonary dysplasia in very low birthweight newbornsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.